Insider
Medtronic plcMDT

Medtronic has completed the divestiture of its MiniMed assets and received notice of insider stock sales

Medtronic has completed an exchange of shares for its interest in MiniMed Group, accepting 55,032,401 of its own shares. This action completes the company's divestiture of all remaining interest in MiniMed.

Verified against 6 archived primary sources · SHA-256 recorded Inspect sources & citations ↓
a close up of a computer screen with candles in the background
Photo by Dimitri Karastelev on Unsplash
55,032,401
Medtronic shares accepted
18.289133%
Final proration factor
297,521,390
Shares validly tendered

Key points

  • Medtronic accepted a total of 55,032,401 of its own shares, including 5,975,762 additional shares it elected to accept due to high demand.
  • Previously, in September 2026, the company announced the start of an offer to exchange up to 225,361,295 MiniMed shares, representing approximately 80.1% of that company's capital.

Exchange offer results.

Medtronic accepted a total of 55,032,401 of its own shares, including 5,975,762 additional shares it elected to accept due to high demand. A total of 252,813,348 shares of MiniMed Group were exchanged for these securities. The exchange agent calculated that 297,521,390 Medtronic shares were validly tendered.

Due to high demand, the company applied a proration procedure to participants. The final proration factor was 18.289133%. An exception was made for odd-lot holders (an odd-lot is a holding of fewer than 100 shares, which are not subject to proration), allowing them to avoid adjustment of the number of shares exchanged.

Proposed sales (Form 144), by insider

Marinaro Michael$1,000,320Martha Geoffrey$4,750,000
Data from the original sources listed alongside.

Deal context.

Previously, in September 2026, the company announced the start of an offer to exchange up to 225,361,295 MiniMed shares, representing approximately 80.1% of that company's capital. Terms set a ratio of 4.5939 MiniMed shares for each Medtronic share received.

Insider intentions and next steps.

In addition to completing the exchange, two insiders reported intentions to sell Medtronic shares on October 15, 2026. Martha Geoffrey plans to sell 50,000 shares under a trading plan adopted in July 2026. Michael Marinaro filed a notice of intent to sell 10,420 shares. A notice of intent to sell shares does not mean the sale has already occurred.

Original sources

  1. SC TO-I/A filing, October 13, 2026October 13, 2026SHA-256 of our archived copy 6e3b8177bfe9…
  2. SC TO-I/A filing, October 14, 2026October 14, 2026SHA-256 of our archived copy 9e82f768ee29…
  3. 144 filing, October 15, 2026October 15, 2026SHA-256 of our archived copy 3d97c11ef9fd…
  4. 144 filing, October 15, 2026October 15, 2026SHA-256 of our archived copy a982ffb1caf2…
  5. 8-K filing, September 17, 2026September 17, 2026SHA-256 of our archived copy 1a5a66cc9ade…
  6. SC TO-I/A filing, October 8, 2026October 8, 2026SHA-256 of our archived copy bfd482e0ddb7…
Cite this article

The fingerprint identifies the exact version of each original that the article was written from; the original stays at its source.

Prepared by AI from official company documents; automatic checks and an AI editor review it before publication, and not every article is read by a person. This is not investment advice. Editorial standards